Altamira Therapeutics Ltd.

Biotechnology • Healthcare • Hamilton, Bermuda • CYTOF (PNK)

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens It is also developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; and AM-125 that is in post phase II clinical trial for the intranasal treatment of vertigo. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda.

441 295 5950 Clarendon House, Bermuda

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Nasdaq Announces Delisting of Multiple Companies Including Blue Star Foods Corp, Altamira Therapeutics Ltd, and Others - Quiver Quantitative

Quiver Quantitative • Jun 11

Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets - Yahoo Finance

Yahoo Finance • Dec 20

Major Nasdaq Purge: 12 Companies Face Final Delisting After Trading Suspensions - Stock Titan

Stock Titan • Jun 11

Altamira Therapeutics Ltd. to Transition from Nasdaq to OTCQB Following Delisting Decision - Nasdaq

Nasdaq • Dec 20

Nasdaq de-lists Altamira shares - Royal Gazette | Bermuda

Royal Gazette | Bermuda • Dec 26

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Altamira Therapeutics Ltd. had layoffs?

No layoff events have been recorded for Altamira Therapeutics Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Altamira Therapeutics Ltd. have?

Altamira Therapeutics Ltd. has approximately 11 employees.

What industry is Altamira Therapeutics Ltd. in?

Altamira Therapeutics Ltd. operates in the Biotechnology industry, within the Healthcare sector.

Is Altamira Therapeutics Ltd. a publicly traded company?

Yes, Altamira Therapeutics Ltd. is publicly traded under the ticker symbol CYTOF on the PNK. The company has a market capitalization of approximately $0.00 billion.

Where is Altamira Therapeutics Ltd. headquartered?

Altamira Therapeutics Ltd. is headquartered in Hamilton, Bermuda at Clarendon House, Bermuda.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.